Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 17 studies | 65% ± 21% | |
oligodendrocyte | 14 studies | 39% ± 11% | |
glutamatergic neuron | 13 studies | 62% ± 21% | |
oligodendrocyte precursor cell | 12 studies | 39% ± 13% | |
GABAergic neuron | 11 studies | 49% ± 22% | |
interneuron | 6 studies | 62% ± 17% | |
neuron | 5 studies | 44% ± 11% | |
endothelial cell | 5 studies | 37% ± 19% | |
granule cell | 4 studies | 50% ± 17% | |
GABAergic interneuron | 3 studies | 56% ± 4% | |
ependymal cell | 3 studies | 52% ± 17% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 17 studies | 48% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4443.15 | 2636 / 2642 | 93% | 15.10 | 657 / 705 |
stomach | 73% | 2964.52 | 263 / 359 | 23% | 1.25 | 67 / 286 |
bladder | 33% | 305.90 | 7 / 21 | 30% | 1.11 | 152 / 504 |
pancreas | 40% | 385.05 | 132 / 328 | 19% | 0.53 | 33 / 178 |
adrenal gland | 1% | 9.27 | 3 / 258 | 41% | 1.26 | 94 / 230 |
breast | 7% | 50.64 | 34 / 459 | 19% | 0.65 | 213 / 1118 |
esophagus | 0% | 5.80 | 4 / 1445 | 19% | 0.94 | 35 / 183 |
lung | 0% | 0 | 0 / 578 | 14% | 0.55 | 161 / 1155 |
prostate | 4% | 23.38 | 9 / 245 | 9% | 0.24 | 43 / 502 |
intestine | 2% | 15.05 | 17 / 966 | 9% | 0.26 | 47 / 527 |
kidney | 1% | 8.18 | 1 / 89 | 6% | 0.29 | 58 / 901 |
uterus | 0% | 0 | 0 / 170 | 7% | 0.33 | 31 / 459 |
thymus | 0% | 0 | 0 / 653 | 5% | 0.14 | 29 / 605 |
ovary | 0% | 0 | 0 / 180 | 1% | 0.03 | 6 / 430 |
skin | 1% | 3.49 | 11 / 1809 | 0% | 0.00 | 1 / 472 |
liver | 0% | 0 | 0 / 226 | 0% | 0.00 | 1 / 406 |
adipose | 0% | 0.55 | 1 / 1204 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0 | 0 / 1335 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0009312 | Biological process | oligosaccharide biosynthetic process |
GO_1903037 | Biological process | regulation of leukocyte cell-cell adhesion |
GO_0010976 | Biological process | positive regulation of neuron projection development |
GO_0036445 | Biological process | neuronal stem cell division |
GO_0106402 | Biological process | Lewis x epitope biosynthetic process |
GO_0036065 | Biological process | fucosylation |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0000271 | Biological process | polysaccharide biosynthetic process |
GO_0042355 | Biological process | L-fucose catabolic process |
GO_1903236 | Biological process | regulation of leukocyte tethering or rolling |
GO_0036071 | Biological process | N-glycan fucosylation |
GO_0030182 | Biological process | neuron differentiation |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0006688 | Biological process | glycosphingolipid biosynthetic process |
GO_0006486 | Biological process | protein glycosylation |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0032588 | Cellular component | trans-Golgi network membrane |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0000139 | Cellular component | Golgi membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0008417 | Molecular function | fucosyltransferase activity |
GO_0017083 | Molecular function | 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase activity |
GO_0046920 | Molecular function | alpha-(1->3)-fucosyltransferase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FUT9 |
Protein name | Alternative protein FUT9 (cDNA FLJ52603) 4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase 9 (EC 2.4.1.152) (Fucosyltransferase 9) (Fucosyltransferase IX) (Fuc-TIX) (FucT-IX) (Galactoside 3-L-fucosyltransferase) Fucosyltransferase (EC 2.4.1.-) |
Synonyms | hCG_16703 |
Description | FUNCTION: Catalyzes alpha(1->3) linkage of fucosyl moiety transferred from GDP-beta-L-fucose to N-acetyl glucosamine (GlcNAc) within type 2 lactosamine (LacNAc, beta-D-Gal-(1->4)-beta-D-GlcNAc-) glycan attached to glycolipids and N- or O-linked glycoproteins. Fucosylates distal type 2 LacNAc and its fucosylated (H-type 2 LacNAc) and sialylated (sialyl-type 2 LacNAc) derivatives to form Lewis x (Lex) (CD15) and Lewis y (Ley) antigenic epitopes involved in cell adhesion and differentiation . Generates Lex epitopes in the brain, presumably playing a role in the maintenance of neuronal stemness and neurite outgrowth in progenitor neural cells (By similarity). Fucosylates the internal type 2 LacNAc unit of the polylactosamine chain to form VIM-2 antigen that serves as recognition epitope for SELE . Can also modify milk oligosaccharides, in particular type 2 tetrasaccharide LNnT . . |
Accessions | Q9Y231 ENST00000302103.6 B4DEW1 Q5Q0U2 |